ArticleIranian journal of biotechnology2018

Expression and Evaluation of HuscFv Antibody -PE40 Immunotoxin for Target Therapy of EGFR-Overexpressing Cancers.

Dianoush Falahatgar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.